These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21605113)

  • 21. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
    Jarchum I; Baker JC; Yamada T; Takaki T; Marron MP; Serreze DV; DiLorenzo TP
    Diabetes; 2007 Oct; 56(10):2551-60. PubMed ID: 17620420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
    Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
    J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.
    Jarchum I; DiLorenzo TP
    J Immunol; 2010 Jan; 184(2):658-65. PubMed ID: 19966211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
    Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
    Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.
    Lieberman SM; Evans AM; Han B; Takaki T; Vinnitskaya Y; Caldwell JA; Serreze DV; Shabanowitz J; Hunt DF; Nathenson SG; Santamaria P; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8384-8. PubMed ID: 12815107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T; Kawamura K; von Grafenstein H
    J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
    J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.
    Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA
    Diabetes; 2011 Jun; 60(6):1726-33. PubMed ID: 21521873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
    Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
    Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
    Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
    Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
    Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
    Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines.
    Fuchs YF; Jainta GW; Kühn D; Wilhelm C; Weigelt M; Karasinsky A; Upadhyaya B; Ziegler AG; Bonifacio E
    Clin Immunol; 2015 Apr; 157(2):216-25. PubMed ID: 25728493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.